Press review: Trump terrifies Western elites and Alibaba eyes partnership with SberbankPress Review January 18, 13:00
Kremlin knows nothing about Snowden’s intentionsRussian Politics & Diplomacy January 18, 12:50
Russian lawmaker: McCain confirms US recognizes Russia’s growing world roleRussian Politics & Diplomacy January 18, 12:42
Kremlin: Issue on Crimea status not matter of discussion for MoscowRussian Politics & Diplomacy January 18, 12:31
Russia views Austria’s OSCE chairmanship program as pragmaticRussian Politics & Diplomacy January 18, 12:16
New movie marks return of Russian cinema to India’s silver screens after 25-year hiatusSociety & Culture January 18, 12:09
Senator says Russia should not abide by ECHR ruling on adoption ban for USRussian Politics & Diplomacy January 18, 12:00
Stunning Miss Universe 2017 candidatesSociety & Culture January 18, 11:46
Chinese Foreign Ministry: Beijing ready to boost cooperation with MoscowWorld January 18, 11:11
KALUGA, June 5. /TASS/. A new pharmaceutical plant, Nearmedic Pharma, located on the territory of a major innovation and industrial Kaluga region, in central Russia, is starting manufacturing medicines.
The project worth $73 million is implemented in cooperation with the national holding company Nearmedic and the Russian Corporation of Nanotechnologies, the press service of Nearmedic Plus told TASS.
The new plant complies with international standards GMP, ISO and FDA. The total annual output reaches up to 100 million medical products, including anti-viral medications.
"The plant is unique as the whole cycle from the synthesis of incoming substances to manufacturing of finished pharma products comes in the framework of one production unit and the product range is the company’s innovations," the press service said.
All the pharmaceutical companies in Russia's Kaluga region are united in a single pharma cluster which now consists of 54 companies.